Ben Chandler's Avatar

Ben Chandler

@benjaminhchandler.com.bsky.social

Postbac research fellow at NIMH and aspiring psychiatrist-neuroscientist. Cat dad to Tipper ๐Ÿ˜ป. Born Michigander. Views are my own. benjaminhchandler.com

129 Followers  |  421 Following  |  4 Posts  |  Joined: 08.06.2025  |  1.5138

Latest posts by benjaminhchandler.com on Bluesky

Post image

Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj

20.06.2025 21:21 โ€” ๐Ÿ‘ 4    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
It's disappointing โ€” but not surprising โ€” that journalists with close ties to MAPS have resorted to such a transparently partisan political attack. This piece is an opportunistic attempt to politicize whistleblowers with a narrative that appeals to the Trump administration. While Jacobs and Nuwer attack Psymposia and me personally, they have failed to refute our core claims, which remain important and unrebutted. To be clear, their attacks are flatly incorrect and underscore their desperation to distract from the real story: that MAPSโ€™s handling of its clinical trials was a disaster, and that Lykos is in financial disarray.

To obscure this fact, the article offered a caricature of my research and of Psymposia's broader work in the field. I describe my actual motivations in a recent AJOB commentary: Lykos has never acknowledged how the on-camera physical and sexual abuse from its Phase 2 clinical trial was enabled by the therapy's reliance on Grofian โ€œfocused bodywork.โ€ The Phase 2 participant had tried to alert the FDA to this connection for years, and it was only after those initial attempts were unsuccessful that we felt obligated to communicate this to the advisory committee, before this dangerous practice could be scaled.

If MAPS had listened to this participantโ€™s concerns when the abuse took place, they could have made their therapy safer years ago. I am not opposed to the psychedelic industry, but to the normalization of pseudoscientific practices when vulnerable groups are at stake.

It's disappointing โ€” but not surprising โ€” that journalists with close ties to MAPS have resorted to such a transparently partisan political attack. This piece is an opportunistic attempt to politicize whistleblowers with a narrative that appeals to the Trump administration. While Jacobs and Nuwer attack Psymposia and me personally, they have failed to refute our core claims, which remain important and unrebutted. To be clear, their attacks are flatly incorrect and underscore their desperation to distract from the real story: that MAPSโ€™s handling of its clinical trials was a disaster, and that Lykos is in financial disarray. To obscure this fact, the article offered a caricature of my research and of Psymposia's broader work in the field. I describe my actual motivations in a recent AJOB commentary: Lykos has never acknowledged how the on-camera physical and sexual abuse from its Phase 2 clinical trial was enabled by the therapy's reliance on Grofian โ€œfocused bodywork.โ€ The Phase 2 participant had tried to alert the FDA to this connection for years, and it was only after those initial attempts were unsuccessful that we felt obligated to communicate this to the advisory committee, before this dangerous practice could be scaled. If MAPS had listened to this participantโ€™s concerns when the abuse took place, they could have made their therapy safer years ago. I am not opposed to the psychedelic industry, but to the normalization of pseudoscientific practices when vulnerable groups are at stake.

My personal response to the propagandistic & defamatory New York Times article on Psymposia @psymposia.bsky.social, which violated the Times' editorial standards. This transparently partisan attack politicized whistleblowers to appeal to the Trump administration on behalf of a pharmaceutical company

06.02.2025 18:34 โ€” ๐Ÿ‘ 28    ๐Ÿ” 8    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

๐Ÿ‘๐Ÿป

18.06.2025 15:45 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Iโ€™m intrigued ๐Ÿง it makes sense!

16.06.2025 23:08 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Keep your eyes peeled for โ€œResting-state spectral power markers of insular dysregulation in suicide attempt historyโ€ ๐Ÿ‘€ @sfn.org #SfN2025

08.06.2025 23:47 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
(PDF) Examining the effects of estradiol and COMT polymorphism on a neural correlate of error awareness [Undergraduate thesis, Michigan State University] PDF | A two-semester independent study project under the supervision of the principal investigator (Jason S. Moser, Ph.D.) and a clinical psychology... | Find, read and cite all the research you need ...

My undergraduate thesis "Examining the effects of estradiol and COMT polymorphism on a neural correlate of error awareness" (2023) is now available on @researchgate.bsky.social:

www.researchgate.net/publication/...

08.06.2025 23:46 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@benjaminhchandler.com is following 20 prominent accounts